KMG Fiduciary Partners LLC increased its position in MetLife, Inc. (NYSE:MET – Free Report) by 6.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 54,513 shares of the financial services provider’s stock after acquiring an additional 3,257 shares during the quarter. KMG Fiduciary Partners LLC’s holdings in MetLife were worth $4,464,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in MET. MeadowBrook Investment Advisors LLC grew its holdings in MetLife by 244.4% during the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after buying an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. boosted its position in shares of MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after acquiring an additional 186 shares during the last quarter. Wolff Wiese Magana LLC lifted its position in MetLife by 374.3% in the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after buying an additional 277 shares during the last quarter. Peterson Financial Group Inc. bought a new stake in MetLife in the 3rd quarter worth approximately $30,000. Finally, Fortitude Family Office LLC lifted its position in MetLife by 177.3% in the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after buying an additional 266 shares during the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.
Analyst Ratings Changes
A number of research firms recently weighed in on MET. Barclays boosted their target price on MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, January 6th. Piper Sandler boosted their target price on MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Jefferies Financial Group boosted their price objective on MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 27th. JPMorgan Chase & Co. boosted their price objective on MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Finally, Wells Fargo & Company lowered their price objective on MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a research report on Tuesday. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, MetLife currently has an average rating of “Moderate Buy” and an average price target of $89.92.
MetLife Price Performance
Shares of MET stock opened at $85.90 on Friday. The stock has a market cap of $59.48 billion, a price-to-earnings ratio of 17.32, a PEG ratio of 0.59 and a beta of 1.07. The business’s fifty day moving average is $83.19 and its 200 day moving average is $79.24. MetLife, Inc. has a twelve month low of $64.61 and a twelve month high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51.
MetLife Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be paid a $0.545 dividend. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 annualized dividend and a yield of 2.54%. MetLife’s payout ratio is 43.95%.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- Insider Buying Explained: What Investors Need to Know
- Top Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- Stock Dividend Cuts Happen Are You Ready?
- Is Johnson & Johnson Stock Set to Reward Long-Term Holders?
- What is the Nasdaq? Complete Overview with History
- Buffett’s Sale of BAC Stock: A Smart Move or Missed Opportunity?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.